More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> China Nixes Proposal to Grant WHO Rapid Access to Outbreak Sites in Critical Talks About Pandemic Response 10/01/2022 Kerry Cullinan & Elaine Ruth Fletcher China wants to delete language supporting rapid World Health Organization (WHO) access to outbreak sites in future pandemics from a critical document that maps out a way forward in future pandemics, a diplomatic source has told Health Policy Watch. This emerged at Monday’s start of a three-day meeting in Geneva of the global body’s Working […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Omicron Hospitalizations 40% Lower, New British Study Finds 23/12/2021 Elaine Ruth Fletcher A major new British study has provided encouraging data that people infected with the Omicron variant are 20% less like to visit a hospital and 40% less likely to be admitted overnight than those with the Delta variant. The Imperial College study, published Thursday, looked at everyone with a confirmed infection of either variant in […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
Throat Swab? Nose? Best Test Yet of Omicron’s Spread May be a Sewage Sample 14/01/2022 Maayan Hoffman Two years into the COVID-19 pandemic, monitoring sewage for evidence of disease – in this case COVID-19 – may be on the verge of becoming mainstream. At least that is what some trend-setting researchers are hoping to detect rising SARS-CoV2 infections early and set policies based on data even before swab testing can provide it. […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> China Nixes Proposal to Grant WHO Rapid Access to Outbreak Sites in Critical Talks About Pandemic Response 10/01/2022 Kerry Cullinan & Elaine Ruth Fletcher China wants to delete language supporting rapid World Health Organization (WHO) access to outbreak sites in future pandemics from a critical document that maps out a way forward in future pandemics, a diplomatic source has told Health Policy Watch. This emerged at Monday’s start of a three-day meeting in Geneva of the global body’s Working […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Omicron Hospitalizations 40% Lower, New British Study Finds 23/12/2021 Elaine Ruth Fletcher A major new British study has provided encouraging data that people infected with the Omicron variant are 20% less like to visit a hospital and 40% less likely to be admitted overnight than those with the Delta variant. The Imperial College study, published Thursday, looked at everyone with a confirmed infection of either variant in […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> China Nixes Proposal to Grant WHO Rapid Access to Outbreak Sites in Critical Talks About Pandemic Response 10/01/2022 Kerry Cullinan & Elaine Ruth Fletcher China wants to delete language supporting rapid World Health Organization (WHO) access to outbreak sites in future pandemics from a critical document that maps out a way forward in future pandemics, a diplomatic source has told Health Policy Watch. This emerged at Monday’s start of a three-day meeting in Geneva of the global body’s Working […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Omicron Hospitalizations 40% Lower, New British Study Finds 23/12/2021 Elaine Ruth Fletcher A major new British study has provided encouraging data that people infected with the Omicron variant are 20% less like to visit a hospital and 40% less likely to be admitted overnight than those with the Delta variant. The Imperial College study, published Thursday, looked at everyone with a confirmed infection of either variant in […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
Bangladesh Produces First Generic of Pfizer’s Antiviral But Indian Company Hits Snag with its Merck Generic 11/01/2022 Kerry Cullinan The first generic version of Paxlovid, the Pfizer pill that has proven highly effective in treating COVID-19, is already available in Bangladesh. However, Indian generic company Dr Reddy’s, which has started to produce the Merck antiviral, molnupiravir, might be in trouble after the country’s National Task Force for COVID-19 resolved on Monday that there were […] Continue reading -> China Nixes Proposal to Grant WHO Rapid Access to Outbreak Sites in Critical Talks About Pandemic Response 10/01/2022 Kerry Cullinan & Elaine Ruth Fletcher China wants to delete language supporting rapid World Health Organization (WHO) access to outbreak sites in future pandemics from a critical document that maps out a way forward in future pandemics, a diplomatic source has told Health Policy Watch. This emerged at Monday’s start of a three-day meeting in Geneva of the global body’s Working […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Omicron Hospitalizations 40% Lower, New British Study Finds 23/12/2021 Elaine Ruth Fletcher A major new British study has provided encouraging data that people infected with the Omicron variant are 20% less like to visit a hospital and 40% less likely to be admitted overnight than those with the Delta variant. The Imperial College study, published Thursday, looked at everyone with a confirmed infection of either variant in […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
China Nixes Proposal to Grant WHO Rapid Access to Outbreak Sites in Critical Talks About Pandemic Response 10/01/2022 Kerry Cullinan & Elaine Ruth Fletcher China wants to delete language supporting rapid World Health Organization (WHO) access to outbreak sites in future pandemics from a critical document that maps out a way forward in future pandemics, a diplomatic source has told Health Policy Watch. This emerged at Monday’s start of a three-day meeting in Geneva of the global body’s Working […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Omicron Hospitalizations 40% Lower, New British Study Finds 23/12/2021 Elaine Ruth Fletcher A major new British study has provided encouraging data that people infected with the Omicron variant are 20% less like to visit a hospital and 40% less likely to be admitted overnight than those with the Delta variant. The Imperial College study, published Thursday, looked at everyone with a confirmed infection of either variant in […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Omicron Hospitalizations 40% Lower, New British Study Finds 23/12/2021 Elaine Ruth Fletcher A major new British study has provided encouraging data that people infected with the Omicron variant are 20% less like to visit a hospital and 40% less likely to be admitted overnight than those with the Delta variant. The Imperial College study, published Thursday, looked at everyone with a confirmed infection of either variant in […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Omicron Hospitalizations 40% Lower, New British Study Finds 23/12/2021 Elaine Ruth Fletcher A major new British study has provided encouraging data that people infected with the Omicron variant are 20% less like to visit a hospital and 40% less likely to be admitted overnight than those with the Delta variant. The Imperial College study, published Thursday, looked at everyone with a confirmed infection of either variant in […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
Omicron Hospitalizations 40% Lower, New British Study Finds 23/12/2021 Elaine Ruth Fletcher A major new British study has provided encouraging data that people infected with the Omicron variant are 20% less like to visit a hospital and 40% less likely to be admitted overnight than those with the Delta variant. The Imperial College study, published Thursday, looked at everyone with a confirmed infection of either variant in […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts
Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Posts navigation Older postsNewer posts